SAN DIEGO–(BUSINESS WIRE)–Amprion, a global leader advancing diagnosis of neurodegenerative disorders through seed amplification testing, today announced publication of new peer-reviewed research in npj Parkinson’s Disease, a Nature Portfolio journal, demonstrating that its skin-based ?-synuclein seed amplification assay (skin SAA) can differentiate multiple system atrophy (MSA) from neuronal synuclein diseases (NSD), including Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), rep
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
